METHOD FOR PREDICTION OF OVARIAN CANCER PERITONEAL PROPAGATION Russian patent published in 2020 - IPC A61B5/00 G01N33/68 G01N33/574 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for prediction of peritoneal propagation of ovarian cancer. Content of HE-4 protein is determined in tissues of greater omentum and peritoneum by enzyme immunoassay. If its level in the omentum is equal to 426.6 units/g of tissue and above, and the level in peritoneum tissue equal to 312.4 units/g of tissue and higher, development of implantation metastases within the abdominal cavity within the period of up to 6 months is predicted.

EFFECT: method provides the possibility of determining, at the stage of surgical removal of the tumor, the character of the further development of the malignant process in patients suffering ovarian cancer, id est to carry out early diagnosis of metastases of ovarian cancer in the peritoneum by determining the content of protein HE-4 in tissues of omentum and peritoneum.

1 cl, 1 tbl, 2 ex